TickerFacts.

TScan Therapeutics, Inc. (TCRX): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

-$132.91M
Year ended 2025-12-31
2020-12-31: -$25.03M2021-12-31: -$45.34M2022-12-31: -$61.54M2023-12-31: -$88.06M2024-12-31: -$130.72M2025-12-31: -$132.91M-$132.91M
2020-12-31 EBITDA (USD) 2025-12-31
Period endedEBITDAChange YoYSource filing
2025-12-31-$132.91Mn/m2026-03-04, From 2025-01-01
2024-12-31-$130.72Mn/m2026-03-04, From 2024-01-01
2023-12-31-$88.06Mn/m2025-03-05, From 2023-01-01
2022-12-31-$61.54Mn/m2024-03-06, From 2022-01-01
2021-12-31-$45.34Mn/m2023-03-08, From 2021-01-01
2020-12-31-$25.03Mn/a2022-03-09, From 2020-01-01

EBITDA at similar companies

Companies with the same SEC industry code (Biological Products, (No Diagnostic Substances)), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
TScan Therapeutics, Inc. (TCRX)2025-12-31-$132.91Mn/m
Alpha Cognition Inc. (ACOG)2025-12-31-$22.60Mn/m
Caribou Biosciences, Inc. (CRBU)2025-12-31-$144.70Mn/m
Curis Inc (CRIS)2025-12-31-$5.54Mn/m
Lineage Cell Therapeutics, Inc. (LCTX)2025-12-31-$35.92Mn/m
Fate Therapeutics Inc (FATE)2025-12-31-$134.80Mn/m
DBV Technologies S.A. (DBVT)2025-12-31-$144.07Mn/m
LENZ Therapeutics, Inc. (LENZ)2025-12-31-$90.85Mn/m
Zeo ScientifiX, Inc. (ZEOX)2025-10-31-$5.31Mn/m

Compare TCRX, ACOG, CRBU, CRIS side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗